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Expression of adhesion molecules in rat renal cortex during experi-
mental hydronephrosis. Unilateral ureteral obstruction (UUO) is associ-
ated with an early and steadily increasing infiltration of macrophages into
the renal cortical interstitium. As adhesion molecules may play an
important role in macrophage recruitment following the mechanical
disturbance after UUO, we delineated the time course of intercellular
adhesion molecule (ICAM)-1 and vascular adhesion molecule (VCAM)-1
mRNA and protein expression. A significant 6.6- (P < 0.001), 2.6- (P <
0.025), 2.6- (P < 0.01), and 2.0-fold (P < 0.005) increase in ICAM-1
mRNA expression was observed at 12, 24, 48, and 96 hours after
obstruction, respectively, in comparison to the contralateral unobstructed
kidney (CUK). Despite an apparent relief of obstruction, four weeks
following reversal of obstruction mRNA levels of ICAM-1 remained
equivalent to the 96-hour obstructed kidney group. No significant differ-
ence in VCAM-1 mRNA expression was observed between the obstructed
kidneys and CUK specimens. Immunohistochemistry revealed focal label-
ing of ICAM-1 on the apical and basolateral surface of the renal tubules,
peritubular interstitium, and vessels of the renal cortex by 12 hours after
UUO. In contrast, only faint staining for ICAM-l protein was observed in
the cortex from CUK specimens. The obstructed and CUK specimens
exhibited diffuse immunolocalization of VCAM-1 in the cortical tubules
and Bowman's capsular epithelium. In situ hybridization showed mRNA
transcription for ICAM-1 localized in the peritubular interstitium and
cortical tubules from obstructed kidneys. To lend mechanistic insight into
the response of ICAM-1 to the mechanical disturbance after UUO, the
expression of ICAM-1 mRNA was examined when freshly isolated
proximal tubules were exposed to angiotensin II (1 to 1000 jsM) immedi-
ately after preparation. Levels of ICAM-1 mRNA were elevated 1.4-, 7.1-,
and 3.7-fold when exposed to 10 sM, 100 /LM and 1000 /.LM of angiotensin
II for one hour, respectively, when compared to control cultures. The
addition of losartan to proximal tubules for one hour prior to angiotensin
II stimulation decreased ICAM-1 levels to control values. In summary, this
investigation demonstrates that ICAM-1 is important in the initiation of
macrophage recruitment into the renal cortex of the obstructed kidney.
These findings provide evidence that angiotensin II, produced after
ureteral ligation as a result of tubular injury and dysfunction, may play a
central role in the release of ICAM-l from the proximal tubule epithelial
cells.
Our laboratory has developed a cell-mediated model for pro-
gressive nonimmune renal injury involving macrophages, up-
regulated transforming growth factor (TGF)-13 expression, extra-
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cellular matrix accumulation, and eventual scarring of the
tubulointerstitial compartment [1]. Recently, we have focused our
attention [2, 3] on the chemoattractant events and subsequent
florid cortical interstitial macrophage accumulation that develops
within hours of ureteral ligation in a rat model of obstructive
nephropathy, pioneered by Klahr and colleagues [4, 5]. Thus far
we have shown that there is a dramatic up-regulation of monocyte
chemoattractant (MCP)-1 [21 and osteopontin [31 within hours
after the mechanical disturbance of ureteral ligation is initiated.
Peptides may not be the only group of macrophage chemoattrac-
tant moieties in this model. Rovin et al [6] have demonstrated that
acute ureteral obstruction results in the release of a specific
chemoattractant that is a lipid.
Renal interstitial macrophage influx is one of the earliest
responses of the kidney to ureteral obstruction. Schreiner et al [7]
observed an initial macrophage infiltrate within four hours after
unilateral ureteral obstruction (UUO), with a peak response by 24
hours and stabilizing thereafter. They found that the mononuclear
cell infiltrate in the obstructed kidney consisted primarily of
macrophages, with T lymphocytes of the cytotoxic suppressor cell
subclass accounting for a subordinate portion of the cell infiltrate
[7]. Our studies on interstitial macrophage numbers show that the
parenchymal infiltration develops early, but not until 12 hours
after ureteral ligation, with marked serial increments in cortical
interstitial macrophage number continuing to rise through to 96
hours. ED-I-positively labeled macrophages were observed al-
most exclusively in the peritubular cortical interstitial space in a
ring-like pattern and with the majority of macrophage clusters
around glomeruli [2, 3].
Recently, the role of adhesion molecules in the accumulation of
inflammatory cells and matrix molecules in the kidney has gar-
nered increasing attention. Intracellular adhesion molecule
(ICAM)-1 (CD 54) is a cell surface glycoprotein that is constitu-
tively expressed by endothelial cells, and its expression can be
induced on other cell types such as mesangial cells and epithelial
cells by pro-inflammatory cytokines such as interleukin (IL)-1,
tumor necrosis factor (TNF), and y-interferon (IFN) [8, 9].
ICAM-1 plays a major role in macrophage and T-lyniphocyte
adhesion to activated endothelium via binding to the ligand,
lymphocyte function-associated antigen (LFA)-1 [9]. LFA-1 is a
member of the f32 integrin family and is expressed on most
leukocytes [10]. Vascular cell adhesion molecule (VCAM)-1 is
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constitutively expressed at low levels by endothelial cells and can
also be induced on endothelial cells and other cell types by
cytokines [11]. VCAM-1 supports adhesion of monocytes, eosin-
ophils, basophils, and lymphocytes, but not neutrophils.
The UUO model of obstructive nephropathy is associated with
an early and steadily increasing renal cortical macrophage infil-
trate [2]. We have delineated the time course of ICAM-1 and
VAM-1 mRNA expression, by Northern analysis, as well as the
mRNA and immunohistochemical localization patterns of
ICAM-1 and VCAM-1 by in situ hybridization and avidin biotin-
ylated peroxidase staining, respectively, in an attempt to demon-
strate that these particular adhesion molecules may play an
important early role in macrophage recruitment into the tubu-
lointerstitium in this typically-viewed nonimmune model of pro-
gressive tubulointerstitial fibrosis. We also utilized reversal of
obstruction (R-UUO), a maneuver that reproducibly yields a
reduction in the renal cortical macrophage infiltrate [3, 7], as an
interventional maneuver to give additional insight into the role of
ICAM-1 in the kidney's response to the mechanical disturbance
produced by UUO. In order to lend mechanistic insight into this
pathobiologic process, we also chose to assess whether angioten-
sin II, which is up-regulated within hours in this model, can
increase the mRNA expression of ICAM-1 in isolated proximal
tubules.
Methods
Animals and tissue preparation
Male Spraguc-Dawlcy rats (Charles River Breeding Laborato-
ries, Wilmington, MA, USA), weighing 150 to 200 g were fed
standard rat chow (5001; Purina Chows, St. Louis, MO, USA) and
given water ad lihilum. With Brevital (50 mg/kg body wt, intra-
peritoneal; E. Lilly, Indianapolis, IN, USA) anesthesia, animals
underwent left proximal urcteral ligation via a midline abdominal
incision.
Both the obstructed kidneys and the contralateral unobstructed
kidney (CUK) specimens were harvested from animals (N = 6
animals/time point) at 12, 24, 48, and 96 hours after UUO. Total
RNA was extracted from renal cortical tissue and was purified for
Northern analysis of rat ICAM-1 and VCAM-1. Midcoronal
sections of the kidneys were also taken for immunohistochemical
labeling and in situ hybridization. For immunohistochemistry,
specimens were initially fixed in periodate-lysine-paraformaldc-
hyde (PLP) for three hours [12]. Serial 6 p. cryostat sections were
cut and stained.
Other groups of rats (N = 6/time point) underwent a reversal of
left ureteral obstruction (R-UUO) according to the methods of
Schreiner et al [7]. Briefly, this maneuver was performed by tying
a ligature over a piece of bisected polyethylene tubing (PE-50), 5
mm in length, that had been passed around the left ureter. The
ureter was subsequently released by removing the PE tubing
without damage to the ureter. R-UUO was performed at 96 hours
after UUO. Our previous studies have revealed that this time
interval corresponds to maximal interstitial macrophage number,
cortical TGF-1 [2], a-smooth muscle actin [13], and tissue
inhibitor of metalloproteinase-l [14] mRNA expression.
At 96 hours post-ureteral ligation, there was marked hydrouret-
eronephrosis of the left kidney and collecting system with prom-
inent pelviectasis. Beginning 96 hours to four weeks following a
release of obstruction, there was a complete resolution of the left
hydronephrosis. The left ureter of rats with R-UUO was seen to
have active peristalsis with only mild residual pelviectasis in the
96-hour post-R-UUO animals. Groups of rats with R-UUO were
sacrificed at 24, 48, 72, and 96 hours and at 1, 2, and 4 weeks after
this intervention to discern whether cortical adhesion molecule
expression is modulated over time in response to this maneuver.
Cortical RNA extraction and Northern hybridization
The cortex was isolated from individual rats in all groups at 4°C
and this tissue was minced and homogenized in cold phosphate-
buffered saline. Total cellular RNA was extracted from the renal
cortex by the acid guanidinium thiocyanate-phenol chloroform
method [15]. Total RNA (20 pg/lane), was denatured and elec-
trophoresed through 1.2% agarose gels containing 0.66 M form-
aldehyde and transferred to nylon filters (Nytran; Schleicher and
Schuell, Keene, NH, USA) by capillary blotting. RNA was
immobilized by baking at 80°C for 30 minutes. The blots were
examined under ultraviolet light in the presence of ethidium
bromide to determine the position of the 28 s and 18 s ribosomal
RNA bands and to assess the integrity of the RNA. The blots were
hybridized in a solution containing 5 mol/liter sodium chloride,
0.05 mol/liter Tris, pH 7.4, 20x dextran sulphate solution, 0.1
mg/mi salmon sperm DNA, and 1.0% sodium dodecyl sulphate
with the addition of the following eDNA probes: rat ICAM-1 [16],
which yields a 0.9 kb mRNA transcript (kindly provided by Dr. T.
Benveniste, University of Alabama, Birmingham, AL, USA), and
rat VCAM-1 which yields a 2.2 kb mRNA transcript (kindly
provided by Dr. T. Collins, Department of Pathology, Brigham
and Women's Hospital, 1-larvard Medical School, Boston, MA,
USA). The eDNA probes were labeled with [32P]deoxycytidine
triphosphate, with a random primer eDNA labeling kit (Boehring-
er-Mannheim, Indianapolis, IN, USA). After hybridization at
65°C for 20 hours, blots were washed and quantitative densitom-
etry was evaluated with an IBM-AT compatible computer (Quan-
tity One, PD1 incorporated, Huntington, NY, USA). The negative
images of the photographs of the formaldehyde gels stained with
ethidium bromide were also scanned for the density of the 28 s
rihosomal band to quantify the amount of RNA loaded onto the
gel, as previously reported [3], thereby correcting for variation in
loading samples. The mRNA levels of rat ICAM-1 and VCAM-1
were expressed as a ratio of the optical density for the specific
adhesion molecule mRNA to that of the optical density of 28 s
ribosomal RNA from the ethidium bromide-stained formalde-
hyde gel. The peak optical density reading of each band on the
autoradiograph is reported as densitometric units.
Immunohistochemical labeling
This technique has been previously described in detail [2, 3].
Briefly, mideoronal kidney sections obtained from both the ob-
structed kidney and CUK specimens, over the 4- to 96-hour study
interval, had endogenous peroxidase activity quenched with 4:1
methanol-hydrogen peroxide solution and endogenous biotin
blocked with avidin D and biotin blocking solutions (Vector
Laboratories, Burlingame, CA, USA). With the use of an avidin-
biotin complex immunoperoxidase system, a series of incubations
were used. First, normal horse serum (1:20, Vector) incubation
for 50 minutes at 25°C was performed. Then sections were
incubated with a mouse monoclonal immunoglobulin G (IgG)
antibody obtained from ascites fluid that recognizes rat ICAM-1
(1:50; Serotec, Oxford, UK) and a mouse monoclonal antibody to
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rat VCAM-1 (1:3200; a gift from Biogen Corp., Cambridge, MA,
USA). Next, a biotinylated horse anti-mouse (rat adsorbed)
antibody (1:150, Vector) was used as the secondary antibody for
one hour at 25°C. An avidin-biotinylated horseradish peroxidase
complex (Vector) incubation was for one hour at 25°C. This was
followed by color development with the chromagen, diaminoben-
zidine (DAB, Sigma), 1 mg/mI in 0.1 mol/liter Tris buffer, to which
0.075 ml of 3% hydrogen peroxide had been added. Sections were
counterstained with 1% methyl green solution for 20 minutes.
Negative controls for immunohistochemistry consisted of replac-
ing each of primary antibodies with equivalent concentrations of
an irrelevant murine monoclonal antibody.
In situ hybridization
The rat ICAM-1 plasmid was linearized with either Eco-RI and
an antisense riboprobe generated with T7 polymerase in the
presence of 35S-labeled UTP (New England Nuclear, Boston,
MA, USA). The 565 base pair riboprobe was separated from
unincorporated precursors using G-50 Quick Spin columns
(Boehringer Mannheim, Indianapolis, IN, USA). Riboprobe in
situ hybridization was performed on 10% neutral buffered forma-
lin-fixed paraffin sections according to established protocols [17].
Sections were alcohol dehydrated and incubated with prehybrid-
ization solution containing, 5 M NaC1, 1 M Tris, 6% Ficoll, 6%
BSA, 6% PVP, 0.5 M EDTA, 10% salmon sperm DNA, and 0.1
mg/mI of yeast tRNA. Tissue sections were hybridized at 50°C
overnight in an identical solution, containing, 50% formamide, I
M DTT, 20% SDS and the 35S-laheled cRNA probe at a specific
activity of 4 X io cpm/xl. After hybridization, the slides were
rinsed in a series of washes, including RNase post-treatment. The
final wash was in 2 X SSC for two hours at 60°C. The slides were
exposed to BioMax autoradiography film (Eastman Kodak Co.,
Rochester, NY, USA) and then dipped in diluted Kodak NTB-2
emulsion and stored at 4°C for one to two weeks. Exposure times
were five days. Sections were developed and counterstained with
hematoxylin. Controls included substituting an sense probe for
the antisense probe used and an incubation in 0.1 mg/ml RNase A
for 90 minutes at 25°C.
Isolation of kidney proximal tubules
Sixteen male Sprague-Dawley rats (250 to 300 g) were anesthe-
tized with ethyl ether (EM Science, Gibbstown, NJ, USA) and the
kidneys perfused with Krebs saline buffer via an infrarenal aortic
cannula for three to five minutes to remove circulating blood cells.
Enzymatic digestion was initiated with a collagenase (type V;
Sigma) perfusate (1750 U/mI). The kidneys were removed, decap-
sulated and the cortex dissected away from the medulla. Renal
proximal tubules were isolated as previously described [181. The
renal cortex from the 16 rats were pooled and finely minced. The
cortical tissue was incubated in 1% collagenase (type V) at 37°C
for 30 to 40 minutes. The resulting homogenate was sieved with a
tea strainer, centrifuged at 6000 RPM for one minute and washed
with Krebs buffered saline. The pellet was centrifuged on a Percoll
(Sigma) density gradient and the fourth band containing 96%
proximal tubule cells [181 was collected. Isolated proximal tubules
were incubated for one hour in Dulbecco's Modified Eagle's
Medium/Hams F12 media containing angiotensin II (Sigma) at a
concentration range of 1 to 1000 xM with or without pre-
treatment with losartan (10 M). Total cellular RNA was ex-
tracted from the isolated proximal tubules for Northern hybrid-
Table 1. Northern analysis of renal cortical ICAM-l expression
after UUO
Time
hours Group
Mean ICAM-1/28 s mRNA
ratios densitometric units N
Magnitude of
difference P value
12 UUO 0.33 0.06 6 6.6-fold <0.001
12 CUK 0.05 0.01 6
24 UUO 0.51 0.10 6 2.6-fold <0.025
24 CUK 0.21 0.04 6
48 UUO 0.18 0.03 6 2.6-fold <0.01
48 CUK 0.07 + 0.01 6
96 UUO 0.55 + 0.06 6 2.0-fold <0.005
96 CUK 0.28 + 0.04 6
Abbreviations are: UUO, unilateral ureteral obstruction; CUK, con-
tralateral unobstructed kidney. Values arc means SEM.
ization and probed for ICAM-1. Experiments were done in
triplicate.
Analytical studies
All values are expressed as means SEM. When multiple groups
were compared, one-way analysis of variance was performed
initially to confirm the presence of significant differences, then
individual comparisons were performed with Student's t-test and
multiple pairwise comparisons according to the method of Bon-
ferroni [191 as appropriate. Statistically significant differences
between groups were defined as P values < 0.05.
Results
Northern analysis studies
By Northern analysis, total cortical mRNA levels for ICAM-1
from the obstructed kidneys were significantly increased com-
pared to the CUK specimens (Table 1). As early as 12 hours
following obstruction, levels of ICAM-1 mRNA from the ob-
structed kidneys showed a significant 6.6-fold (0.33 0.06 vs.
0.05 0.01, P < 0.001) increase compared to the CUK specimens.
Significant increases in ICAM-1 expression, relative to CUK
values, were also observed 24 (0.51 0.1 vs. 0.21 0.04, P <
0.025), 48 (0.18 0.03 vs. 0.07 0.01, P < 0.01), and 96 hours
(0.55 0.06 vs. 0.28 0.04, P < 0.005) after ureteral ligation
where ICAM-1 mRNA levels showed a 2.6-, 2.6-, and 2.0-fold
increase, respectively. Representative autoradiograms for
ICAM-1 expression at 12 and 24 hours post-UUO are shown in
Figures 1 and 2.
No significant difference in VCAM-1 expression was observed
between the obstructed kidney and CUK specimens. Following
UUO, there was no significant difference in renal cortical
VCAM-1 mRNA levels at 12(0.17 0.04 vs. 0.16 0.08, mean
SE), 24 (0.14 0.08 vs. 0.19 0.06), 48 (0.21 0.04 vs. 0.27
0.05), and 96 hours (0.26 0.03 vs. 0.21 0.05), in the obstructed
kidney versus the CUK specimen.
Effect of reversal of obstruction (R-UUO) on ICAM-] steady-state
mRNA levels
Despite the apparent relief of obstruction, the renal cortical
ICAM-1 mRNA levels at two weeks after R-UUO were equiva-
lent to those in the 96 hours obstructed kidney control group
(1.89 0.47 vs. 1.40 0.56). Equivalent mRNA levels were also
ICAM-1
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Fig. 1. Northern blot analysis of total conical RNA probed/br IcAM-1. The mRNA probed for IcAM-1 from obstructed kidneys (lanes ito 6) and the
corresponding CUK specimens (lanes 7 to 12) at 12 hours after UUO are shown (top) in relation to the intact 28 s and 18 5 ribosomal RNA bands
(bottom). A single 0.9 kb transcript for ICAM-1 is apparent in all of the obstructed kidney specimens but not visible in the CUK specimens.
ICAM-1
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Fig. 2. Northern blot analysis of total conical RNA from obstructed kidneys of rats undergoing UUO at 24 hours after ureteral ligation (lanes 1 to 6), and
from the CUK specimens of rats undergoing UUO (lanes 7 to 12). Total cortical RNA was probed for ICAM-1 (top). Intact 28 s and 18 s ribosomal bands
using ethidium bromide staining of agarose gel (bottom).
noted in the previously-obstructed kidneys at four weeks post-R-
UUO compared to the 96-hour obstructed kidneys (0.41 t 0.07
vs. 0.41 0.21).
Immunohistochemical studies
Renal cortical JcAM-1 and VGAM-1 iminunolaheling. The pat-
tern of renal cortical ICAM-1 immunolocalization is shown in
Figure 3. At 12, 24 and 96 hours after UUO, there was focal
staining of ICAM-1 in the peritubular interstitial space and
periglomerular region of the obstructed kidneys (Fig. 3 A, C). At
24 hours after UUO, the renal cortex exhibited an intense
immunolocalization of ICAM-1 on the apical surface of the
cytoplasm of the distal tubules (Fig. 3C). Immunolocalization was
also observed in the perivascular adventitia and endothelial lining
of the cortical arterioles from the obstructed kidneys (Fig. 3F). In
the CUK specimens at this time point, there was only faint
immunostaining for ICAM-1 in the peritubular region and pan-
eta! epithelium of Bowman's capsule (Fig. 3 B, D).
At 12, 24 and 96 hours after obstruction, UUO and CUK
specimens revealed a diffuse immunostaining pattern of VCAM-1
protein in the renal cortex in both tubular epithelium and
Bowman's capsule. Immunolocalization of the cortical interstitial
cells was also noted. There was no difference in the pattern and
intensity of VCAM-1 immunolocalization between the UUO and
CUK specimens for any of the time points observed.
In situ hybridization studies
In situ hybridization showed 35S-labeled riboprobe transcrip-
tion for ICAM-1 in the obstructed kidneys and CUK specimens.
Following ureteral ligation there was an evident increase in the
mRNA signal for ICAM-1 on qualitative assessment of the
autoradiogram. Figure 4 shows a representative field from an
autoradiogram of ICAM-1 expression at 96 hours following
ureteral ligation. Lightfie!d microscopy showed ICAM-1 mRNA
transcription in the proximal tubules and penitubular interstitium
of the renal cortex of 96-hour obstructed kidneys (Fig. 4). The
intensity of ICAM-1 mRNA transcription was higher in the
obstructed kidneys compared to the CUK specimens upon qual-
itative examination (Fig. 4). The specificity of the antisense probe
hybridization signal was demonstrated by the lack of label in
sections hybridized to the sense probe, or following pre-digestion
of tissue sections with RNase.
Effect of angiotensin Il-stimulated proximal tubules on ICAM-1
expression
To examine the gene expression of ICAM-1 in response to
vasoactive products of UUO, Northern analysis was performed on
RNA isolated from proximal tubules in response to angiotensin II.
Following stimulation with 10 jIM of angiotensin II for one hour,
there was a 1.4-fold increase in ICAM-1 mRNA levels (Fig. 5).
ICAM-1 mRNA expression was further elevated 7.1-fold in
isolated proximal tubules cultured with 100 jIM angiotensin II for
one hour. Isolated proximal tubules stimulated with 1000 jIM of
angiotensin II had a 3.7-fold increase in ICAM-1 mRNA in
comparison to control cultures of isolated proximal tubules (Fig.
5). The addition of losartan to proximal tubules for one hour prior
to angiotensin II stimulation decreased ICAM-1 mRNA levels to
control levels (Fig. 6). Isolated proximal tubules stimulated with
angiotensin II that were pre-treated with losartan (10 NI) had
ICAM-1 mRNA levels decreased 2.3-, 1.9-, and 1.9-fold, when
compared to proximal tubules stimulated with 1 jIM, 10 jIM, and
100 jiM of angiotensin II, respectively.
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Fig. 3. Avidin-biotinylated horseradish peroxidase
immunolocalization of ohstmcted and CUK
kidney slices. A. Immunostaining for ICAM-1
antibody in a representative midcoronal Section
from a UUO specimen, 24 hours after
obstruction. ICAM-1 immunolabeling was
typically observed in the pcritubular interstitial
space in the renal Cortex. B. Only faint ICAM-1
labeling was observed in the corresponding
CUK specimen, 24 hours after ureteral ligation.
C. Focal pattern of ICAM-1
immunolocalization in an obstructed kidney, 24
hours after UUO. Immunolabeling was
observed in both the parietal epithelial cells of
the Bowman's capsule (small arrowheads), and
in the apical cytoplasm of the distal tubules
(arrowheads). D. Only weak immunostaining
was observed in the interstitium and
periglomerular regions of the renal cortex in
the CUK specimens, 24 hours after UUO. E
and F. Immunostaining with anti-JCAM-1
antibody on a 24-hour UUO specimen. E.
Intense immunolocalization was noted in the
peritubular interstitium. The arrowheads in F
demonstrate the diffuse staining for ICAM-1 in
the endothelium lining of the cortical vessels
(arrowheads). Immunostaining for ICAM-1 was
also observed in the periadventitial region of
the renal vasculature. Publication of this figure
in color was made possible by a grant from
Merck & Co.
Discussion
The present study demonstrates an early pattern (within 12 hr)
of up-regulated ICAM-1 mRNA expression and increased protein
in the renal cortex of obstructed kidneys from UUO rats when
compared with the CUK specimens. Following four weeks of
R-UUO, levels of ICAM-1 mRNA were not significantly reduced
compared to the 96-hour obstructed kidney specimens despite an
apparent relief of obstruction. No significant difference in
VCAM-1 mRNA expression or protein was observed between
UUO and CUK specimens. Levels of ICAM-1 mRNA were found
to be elevated in freshly isolated proximal tubules exposed to
angiotensin II. Pretreatment of angiotensin Il-stimulated proxi-
mal tubules with losartan decreased ICAM-1 mRNA expression
to control values.
ICAM-1 is expressed in vitro in primary cultures of human
proximal tubules [201 and murine mesangial cells [21]. ICAM-1 is
constitutively expressed in normal kidney in renal vascular endo-
thelium, some parietal epithelial cells of Bowman's capsule, and
occasional interstitial cells [22, 23]. In contrast, VCAM-1 is
normally expressed on parietal epithelial cells of Bowman's
capsule, parts of the proximal tubules and occasionally on endo-
thelial cells of large vessels or peritubular capillaries [23, 24]. In
the present study, immunohistochemistry showed a focal staining
pattern for ICAM-1 in the peritubular and periglomerular region
of the renal cortex of obstructed kidneys. Immunolabeling was
also prominent on the luminal surface of the distal tubules,
adventitia and endothelial lining cells of the cortical vessels. In situ
hybridization revealed ICAM-1 mRNA transcription localized to
the renal tubules and interstitium of the renal cortex.
A number of studies suggest that ICAM-1 plays an important
role in renal immune injury [reviewed in 23, 25]. Marked changes
in ICAM-1 expression have been reported in allograft rejection
[26—28], glomerulonephritis [29—32], and tubulointerstitial in-
flammation [33]. Renal biopsy specimens from patients with
allograft rejection frequently reveal a dramatically induced ex-
pression of ICAM-1 on the luminal surface of proximal tubules,
some distal tubules and collecting ducts, and infiltrating leuko-
cytes [26—28]. Tubular localization of ICAM-1 is usually most
intense in areas of marked leukocyte infiltration [26]. In an
allogenic murine model of acute, lethal graft-versus-host disease,
pretreatment with anti-ICAM-1 and LFA-1 antibodies enhanced
survival and reduced renal injury [34].
Up-regulation of ICAM-1 expression on proximal tubules and
the cortical intcrstitium has been reported in a murine model of
hereditary tubulointerstitial nephritis [331. This disease, where
animals develop progressive and ultimately lethal tubulointersti-
tial nephritis beginning at about four weeks, is associated with
up-regulation of ICAM-1 expression in the renal interstitium, on
infiltrating leukocytes, and on the basolateral surface of renal
S..
Fig. 4. In situ hybridization fbr ICAM-1 mRNA in obstructed and CUK specimens, 96 hours fbllowing UUO. Lightfleld photomicrographs of paraffin
sections (A) reacted with a 35S-labeled antisense ICAM-1 probe from an obstructed kidney, 96 hours after UUO; and (B) the corresponding CUK
specimen, hybridized with a ICAM-1 antisense probe showing oniy faint mRNA transcription. Arrowheads, silver grains represent ICAM-1 mRNA
transcripts localized to the proximal tubules and peritubular interstitium of the renal cortex (X440).
1 2 3 4
Fig. 5. Northern blot analysis of RNA extracted from isolated proxi-
mal tubules probed for ICAM-] in control cultures (lane 1), and
isolated proximal tubules exposed to angiotensin II at concentrations
of 10 ttti, 100 jssi and 1000 suM, fbr one hour, in lanes 2, 3, and 4,
respectively. The mRNA band probed for ICAM-1 (top) is shown in
relation to the 28 s and 18 s ribosomal bands (bottom).
tubules, Administration of anti-ICAM-1 antibody to mice with
established disease resulted in significant reductions in infiltrating
leukocytes and tubular epithelial damage as assessed by light
microscopy [33].
In an experimental model for active or passive anti-glomerular
basement membrane disease in rats, recent investigations re-
vealed a central role for ICAM/LFA-1 interactions in the accu-
mulation of leukocytes into the glomerulus and tubulointerstitial
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Fig. 6. Northern blot analysis of RNA extracted from
isolated proximal tubules probed for ICAM-1. Shown are
mRNA from a control one hour proximal tubular sus-
pension (lane 1), proximal tubules exposed to angioten-
sin II at concentrations of 1 jM, 10 M, and 100 jLM, in
Lanes 2, 3, and 4, respectively, and proximal tubules
stimulated with angiotensin 11(100 j.M) pretreated with
losartan (10 lane 5). The mRNA probed for
ICAM- (top) in relation to the 28 s and 18 s ribosomal
RNA bands (bottom) are shown.
region [29—31]. The simultaneous administration of anti-ICAM-1
and anti-LFA-1 monoclonal antibodies prevented the develop-
ment of proteinuria, influx of inflammatory cells into the glomer-
ulus, and subsequent development of cellular crescents [29].
Recently, Nikolic-Paterson et al [32] demonstrated that the
suppression of experimental glomerulonephritis by the IL-i re-
ceptor antagonist is mediated by inhibition of ICAM-1 expression.
The initial cellular and molecular events leading to interstitial
macrophage infiltration following UUO is fundamental in the
development of tubulointerstitial injury and fibrosis. An increased
cell-surface expression of ICAM-1 may be important in facilitat-
ing macrophage accumulation in the renal interstitium. We have
previously observed [2] an increase in the interstitial macrophage
number in the renal cortical interstitium by 12 hours after UUO,
which continues to increase rapidly thereafter. A dramatic early
up-regulation of ICAM-1 mRNA expression and increased pro-
tein are evident 12 hours after ureteral ligation, suggesting that
increased ICAM-1 expression may be important in directing
macrophage accumulation in the renal cortex. Interstitial macro-
phage numbers are maximally increased at 96 hours after UUO,
decreasing to control kidney levels by four weeks post-release of
obstruction [3]. Following a four week R-UUO, levels of ICAM-1
mRNA were equivalent to the 96-hour left kidney control group
despite the demonstrable decompression of the renal pelvis and
calicyeal system. These data support the contention that a number
of factors play a role in the stimulation of ICAM-1 expression in
the renal cortex following ureteral obstruction. ICAM-i mRNA
expression does not decrease with infiltrating macrophage num-
ber following a release of obstruction, implicating a role for
ICAM-1 in macrophage recruitment into the renal interstitium
following ureteral ligation rather than serving as a marker for
macrophage infiltration.
The stimulus for induction of ICAM-1 on tubular epithelial
cells in the renal cortex after UUO remains unclear. ICAM-1
expression can be up-regulated by pro-inflammatory cytokines
and oxidants. IL-i, TNF-a and y-IFN have been found to enhance
ICAM-1 synthesis by glomerular endothelial cells, mesangial cells
and renal tubular epithelial cells in vitro [10]. Generation of
reactive oxygen species can activate ICAM-1 mRNA expression
and other chemoattractants and adhesion molecules, including
MCP-l and RANTES, in cultured mesangial cells [35].
The present study provides evidence that angiotensin II may be
involved in the activation of cell-surface expression of ICAM-1 on
cortical proximal tubules following ureteral obstruction. Acute
ureteral obstruction causes an initial increase in renal blood flow
due to vasodilator prostaglandins, followed by progressive vaso-
constriction of glomerular arterioles resulting in a marked reduc-
tion in renal blood flow and glomerular filtration rate (GFR). it is
apparent that the renal cortical and medullaiy vasoconstriction
that occurs after only two hours of UUO is due, at least in part, to
enhanced intrarenal renin-angiotensin system activation, resulting
in excessive production of angiotensin Ii [36]. Pimental et al [36]
observed up-regulated renin mRNA in the obstructed kidney as
early as one hour after UUO in rats. This increase in renin mRNA
coincided with elevations in renal renin content, angiotensin 1
converting enzyme (ACE) activity and renal angiotensin II con-
centration [36]. This early time course of angiotensin II up-
regulation after UUO indicates angiotensin II as a possible
stimulus for the expression of ICAM-1, leading to recruitment of
macrophages into the renal interstitium of the obstructed kidney.
The vasoactive effects of intrarenal angiotensin II have been
demonstrated in a variety of models. Increasing support is being
given to proximal tubular angiotensin 11 generation in the medi-
ation of renal perturbations. Angiotensinogen is synthesized by
proximal tubule cells. Radiolabeled renin injected intra-aortically
accumulates in the renal cortex, principally the apical portion of
proximal tubules. ACE is found in greatest concentrations in the
kidney in the proximal tubules. Therefore, the proximal tubule has
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all the components of a local angiotensin-generating system [37,
38], which may be the stimulus for ICAM-1 up-regulated expres-
sion in the rat UUO model. Klahr and colleagues [39] demon-
strated that administration of an angiotensin II receptor antago-
nist and an ACE inhibitor, enalapril, to UUO rats resulted in
amelioration of the expansion of the renal cortical interstitium
and decreased mRNA expression of TGF-pl and collagen IV.
Interstitial macrophage infiltration was not altered by the angio-
tensin II receptor antagonist, but was greatly reduced in the UUO
rats administered enalapril [39]. These studies indicate that the
renin-angiotensin system plays a major role in the development of
tubulointerstitial injury after ureteral obstruction.
In conclusion, our studies document an early up-regulated
ICAM-1 mRNA expression in the renal cortex of obstructed
kidneys, temporally coinciding with interstitial macrophage accu-
mulation. Our immunohistochemical labeling patterns for
ICAM-l were most prominent in the peritubular interstitium,
periglomcrular region and the luminal surface of distal tubule
epithelial cells. Immunolocalization of ICAM-1 protein was also
evident in the adventitia and endothelial lining cells of the renal
vasculatore, ICAM-1 mRNA transcription was localized to the
peritubular interstitium and cortical tubules of the obstructed
kidneys. The present study presents evidence that angiotensin II
may play a central role in the activation of ICAM-1 from proximal
tubule epithelial cells. The mechanical injury to the renal proximal
tubules produced by urinary tract obstruction may induce locally-
generated angiotensin 11-mediated cell-surface expression of
ICAM-i. This activation of ICAM-1 may be important in facili-
tating macrophage accumulation in the renal interstitium, thereby
contributing to the cascade of pro-inflammatory events leading to
the development of interstitial fibrosis.
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